ImmunoBrain Checkpoint Announces Expansion of Board of Directors with Appointment of James M. Mackay, Ph.D.

ImmunoBrain Checkpoint Inc.today announced the appointment of James M. Mackay , Ph.D., to the Board of Directors. Mackay brings decades of biopharma leadership experience to the Company’s Board.